By continuing to use our site, you consent to the processing of cookies, user data (location information, type and version of the OS, the type and version of the browser, the type of device and the resolution of its screen, the source of where the user came from, from which site or for what advertisement, language OS and Browser, which pages are opened and to which buttons the user presses, ip-address) for the purpose of site functioning, retargeting and statistical surveys and reviews. If you do not want your data to be processed, please leave the site.

The Voice of People With Breast Cancer

Education

Our Voices Blog

Clinical Trials Part 3: Clinical Trials That Don’t Involve Testing Drugs

In part 1 of our clinical trials series, we explained that clinical trials allow doctors and researchers to test treatments, medical procedures and therapies for various diseases and conditions. In the second part of the series, we debunked 7 common myths on clinical trials. In both parts, we focused on the type of clinical trials most people think of when they hear clinical trials, studies involving drugs. However, clinical trials can study more than just drug treatments or surgeries. According to Clinical Trials Ontario, they can also be conducted to “test devices, genetic therapies, natural health products, psychotherapies, lifestyle and preventive care interventions, and many other things.”

If you are apprehensive about getting involved in clinical trials that involve drugs or make changes to the treatment/surgery you are currently receiving, you can get more comfortable with clinical trials by looking into non-drug clinical trials. Below, we provide a few clinical trials that are currently recruiting breast cancer patients that don’t administer drugs outside of what you may already be taking.


Title of Study: 
The ONE-MIND Study: Evaluating the Efficacy of Online Mindfulness-Based Cancer Recovery (MBCR) During Chemotherapy Treatment (CT) to Impact Fatigue, Side Effects and Quality of Life (QL) in a Randomized Waitlist Controlled Trial

Patient Population: 
Stage I-III HER 2 normal breast carcinoma

Location(s): 
Alberta

Contact Information:
Linda E Carlson, PhD
403-355-3207
lcarlso@ucalgary.ca

Click HERE for more information.


Title of Study: 
Mobile App Postoperative Home Monitoring After Enhanced Recovery Oncologic Surgery

Patient Population: 
Undergoing breast reconstruction, mastectomy alone under ERAS protocols

Location(s): 
Alberta

Contact Information:
Carmen Webb
403-521-3251
carmen.webb@ahs.ca   

Claire Temple-Oberle
403-521-3012
claire.temple-oberle@ahs.ca

Click HERE for more information.


Title of Study: 
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer

Patient Population: 

  • Histologically confirmed invasive breast cancer 
  • Her-2 negative
  • ER and/or PR positive
  • ER and/or PR negative

Location(s): 

  • British Columbia
  • New Brunswick
  • Newfoundland
  • Ontario
  • Saskatchewan

Contact Information:
Jennifer Ligibel, MD
857-215-2935
BWELStudy@partners.org

Click HERE for more information.


Title of Study: 

A Randomized Controlled Feasibility Study Comparing a Multimodal Prehabilitation Protocol to Normal Care for Women Undergoing Neo-adjuvant Chemotherapy for Breast Cancer

Patient Population: 
Any

Location(s): 
Ontario

Contact Information:
Frances Wright, MD
416-480-4210 ext. 1053
frances.wright@sunnybrook.ca

Apisha Sri
apishanthi.sriskandarajah@sunnybrook.ca

Click HERE for more information.


Title of Study: 

Aerobic Exercise and Cognitive Functioning in Women With Breast Cancer: the ACTIVATE Trial

Patient Population: 
Stage I-III breast cancer

Location(s): 

  • British Columbia
  • Ontario

Contact Information:
Aaliya Merali-Dewji, MSc
604-827-1914
aaliya.merali@ubc.ca

Click HERE for more information.


Title of Study: 

POLARIS: Palbociclib In Hormone Receptor Positive Advanced Breast Cancer: A Prospective Multicenter Non-Interventional Study

Patient Population: 
HR+/HER2- Advanced Breast Cancer

Location(s): 

  • British Columbia
  • Ontario
  • Quebec

Contact Information:
Pfizer
1-800-718-1021
ClinicalTrials.gov_Inquiries@pfizer.com

Click HERE for more information.


Title of Study: 
Ontario-wide Cancer TArgeted Nucleic Acid Evaluation

Patient Population: 
Metastatic breast cancer

Location(s): 
Ontario

Contact Information:
Lailah Ahmed
416-946-4501 ext. 3638
lailah.ahmed@uhn.ca

Click HERE for more information.


These are just a few clinical trials that are available. For more trials, you can visit the Clinical Trials Ontario website or the ClinicalTrials.gov website.

Photo by AllGo - An App For Plus Size People on Unsplash 


The views and experiences expressed through personal stories on Our Voices Blog are those of the authors and their lived experiences. They do not necessarily reflect the position of the Canadian Breast Cancer Network. The information provided has not been medically reviewed and is not intended to be a substitute for professional medical advice. Always seek the guidance of your healthcare team when considering your treatment plans and goals.